PMGC Holdings Inc.

Item 7.01 Regulation FD Disclosure. On September 18, 2026, PMGC Holdings Inc. (the “Company”) issued a press release announcing that the Company and its wholly owned subsidiary, NorthStrive Biosciences Inc., have entered into a payment agreement with Longevity Health Holdings, Inc. securing the royalty payments owed in connection with PMGC’s January 2025 sale of its Elevai Skincare business. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K (“Form 8-K”). The information furnished pursuant to this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description ───────────────────────────────────────────────────────────────────────────────── 99.1 Press Release dated September 18, 2026. 104 Cover Page Interactive Data File (formatted in Inline XBRL).